Medical treatment of thyrotoxicosis

Q J Nucl Med Mol Imaging. 2021 Jun;65(2):113-123. doi: 10.23736/S1824-4785.21.03334-3. Epub 2021 Jan 26.

Abstract

Medical treatment is the primary therapeutic option for thyrotoxicosis/hyperthyroidism. Two groups of causes of thyrotoxicosis (i.e. thyrotoxicosis with hyperthyroidism and thyrotoxicosis without hyperthyroidism) need to be considered for therapeutic reasons. Herein we provide an updated review on the role of conventional medical therapies (i.e. β-blockers, antithyroid drugs [ATDs], corticosteroids, inorganic iodide, perchlorate, cholecystographic agents, lithium, cholestyramine) in the main causes of thyrotoxicosis, starting from the rationale subtending their clinical application.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / pharmacology
  • Antithyroid Agents / chemistry*
  • Antithyroid Agents / pharmacology
  • Cholestyramine Resin / pharmacology
  • Dose-Response Relationship, Drug
  • Humans
  • Iodides / pharmacology
  • Lithium / pharmacology
  • Perchlorates / pharmacology
  • Signal Transduction
  • Thyrotoxicosis / drug therapy*
  • Thyrotoxicosis / physiopathology

Substances

  • Adrenal Cortex Hormones
  • Antithyroid Agents
  • Iodides
  • Perchlorates
  • Cholestyramine Resin
  • Lithium